Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric and neurological disorders using psychedelics. Our lead candidate, lysergide tartrate, targets anxiety, depression, and PTSD, while another candidate, DT402, aims to address core symptoms of autism spectrum disorder. We are dedicated to advancing a new generation of therapeutics to address the underlying causes of these disorders and transform mental health care. Headquartered in New York and trading on Nasdaq (DFTX), we are seeking passionate individuals to join our mission.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level